Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 2/20 | 0.47 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28857131 | 1.00 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL23364705 | 0.92 | MEN1 (0.50) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL15600251 | 0.87 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL16419551 | 0.87 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL16415212 | 0.87 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL16520107 | 0.87 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL8295157 | 0.87 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL2145886 | 0.86 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL31421263 | 0.86 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 | |
| SCHEMBL31421243 | 0.86 | PRMT5 (0.47) | PRMT5WDR77HPGDPIK3CDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4058439-A1 | 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY | Genzyme Corporation (US) | 2022-09-21 | — | — | EP | disclosed |
| CN-115003659-A | 5-membered heteroaryl amino sulfonamides for the treatment of conditions mediated by a deficiency in CFTR activity | 健赞公司 | 2022-09-02 | — | — | CN | disclosed |